| # | Country | Total Patents | |
|---|---|---|---|
| #1 | WIPO (World Intellectual Property Organization) | 5 | |
| #2 | EPO (European Patent Office) | 4 | |
| #3 | United States | 4 | |
| #4 | China | 3 | |
| #5 | Australia | 2 | |
| #6 | Canada | 2 | |
| #7 | Israel | 1 | |
| #8 | Republic of Korea | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Medical technology | |
| #3 | Environmental technology |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Therapeutic chemical compounds | |
| #3 | Syringes | |
| #4 | Object sterilising | |
| #5 | Implantable devices | |
| #6 | Climate change adaptation technologies |
| # | Name | Total Patents |
|---|---|---|
| #1 | Liang Bo | 19 |
| #2 | Baldwin John J | 6 |
| #3 | Wei Gang | 6 |
| #4 | Jin Xiang | 4 |
| #5 | Zhang Ming | 2 |
| #6 | Samson Michael C | 1 |
| #7 | Baldwin John | 1 |
| #8 | Tessema Belachew | 1 |
| #9 | Peng Haizhou | 1 |
| #10 | Lu Yong | 1 |
| Publication | Filing date | Title |
|---|---|---|
| WO2021034850A1 | In-situ gel forming ophthalmic formulations containing difluprednate | |
| WO2021034421A1 | Stable pharmaceutical articles containing dilute povidone iodine formulations | |
| CA3042729A1 | In situ gel-forming pharmaceutical compositions and uses thereof for sinus diseases | |
| WO2018004739A1 | Novel rapid-deposition thin-film forming compositions as effective wound care treatment | |
| CA3002384A1 | Pharmaceutical formulations that form gel in situ | |
| EP2785328A1 | Novel slow-releasing ophthalmic compositions comprising povidone iodine |